Clinical activity of mitogen-activated protein kinase (MAPK) inhibitors in patients with MAP2K1 (MEK1)-mutated metastatic cancers: A systematic review and meta-analysis Meeting Abstract

  


Authors: Dankner, M.; Petrecca, S.; Fabi, F.; Nowakowski, A.; Rajadurai, C. V.; Rousselle, E.; Stein, A.; Bian, D. J.; Tai, P.; Belaiche, A.; Li, M.; Lazaratos, A. M.; Quaiattini, A.; Normanno, N.; Arcila, M. E.; Elkrief, A.; Ladanyi, M.; Rose, A. A. N.
Abstract Title: Clinical activity of mitogen-activated protein kinase (MAPK) inhibitors in patients with MAP2K1 (MEK1)-mutated metastatic cancers: A systematic review and meta-analysis
Meeting Title: 2023 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 41
Issue: 16 Suppl.
Meeting Dates: 2023 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2023-06-01
Language: English
DOI: 10.1200/JCO.2023.41.16_suppl.3125
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:

https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=164013771&authtype=sso&custid=s2915669&site=ehost-live&scope=site&custid=s2915669
Notes: Meeting Abstract: 3125 -- This meeting was also held virtually -- Source: Cinahl
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Marc Ladanyi
    1326 Ladanyi
  2. Maria Eugenia Arcila
    657 Arcila
  3. Arielle Elkrief
    41 Elkrief
Related MSK Work